Construction and characterization of the chimeric antibody 8C11 to the hepatitis E virus
Date
2007Author
Luo, Wenxin
罗文新
Chen, Yingwei
Li, Lifeng
Xu, Chenyu
Miao, Ji
Shih, James Wai-Kou
Zhang, Jun
张军
Xia, Ningshao
夏宁邵
Collections
- 生命科学-已发表论文 [5901]
Abstract
Homodimers of the truncated hepatitis E virus (HEV) capsid proteins, E2 and p239, were conformed to model the dominant antigenic determinants of HEV. Using E2 as an immunogen, two neutralizing monoclonal antibodies (mAbs), namely 8C11 and 8H3, were produced. We constructed a mouse-human chimeric antibody derived from 8C11 and its expression in Chinese hamster ovary (CHO) cells. cDNAs encoding variable regions of heavy and light chains were isolated from hybridoma cells and inserted into mammalian expression vectors containing cDNA of human gamma-1 and kappa constant regions, respectively. The vectors were then cotransfected into CHO cells, and a stable cell line was established. Results from indirect enzyme-linked immunosorbent assay (ELISA) and Western blot analysis showed that the chimeric antibody was assembled correctly to the native IgG molecule and could be secreted from the cells. Similar to the original mAb, the expressed chimeric antibody displayed HEV antigen-binding activity and an enhancement effect on 8H3 binding to HEV antigen. The chimeric antibody could specifically inhibit the binding of p239 to HepG2 cells and compete with HEV IgG in positive serum by antibody-competitive ELISA. The chimeric antibody is expected to be less immunogenic in human and more suitable for antibody therapy of hepatitis E.
Citation
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY,Vol 51 Issue 1,pp18-25URI
http://dx.doi.org/doi:10.1111/j.1574-695X.2007.00253.xhttps://dspace.xmu.edu.cn/handle/2288/10513